Hematopathology

(H001) Signatures of Disease and Resistance: FLT3 in Review

(H002) Clinical Utility of Gene Expression Profiling for Primary Mediastinal Large B-Cell Lymphoma Diagnosis and Treatment

(H003) Rapid NGS Detection of Gene Mutations and Fusions in Myeloid Neoplasms

(H004) "The Challenges of Classifying and Reporting TP53 Variants in Acute Myeloid Leukemia (AML)."

(H005) Evaluation and Comparison of Optical Genome Mapping (OGM) to Standard of Care (SOC) Testing for Hematologic Malignancies on Residual Flow Cytometry Samples in a Clinical Diagnostics Laboratory Setting

(H006) Clinical validation of the new OncomimeTM myeloid assay V2 panel for single-nucleotide variants, insertions/deletions, and fusion genes: challenges, performance and perspectives

(H007) Clinical Validation of the Rapid Acute Myeloid Leukemia Diagnostic Assay on an Automated Next Generation Sequencing System and Associated Impact Analysis

(H008) RNAseq Supplements DNA-based NGS in Confirmation of FLT3-ITD Harboring a Duplicated Splice Site

(H009) Bringing Clonality to the NGS Era. The CGAT Experience with LymphoTrack®.

(H010) CD36 Mutations in hematopoietic neoplasms. A single center cohort of 1599 bone marrow samples

(H011) Advancing Myeloid Cancer Diagnostics with the Integrated Workflow of NGS and NxClinical for Copy Number Analysis: Going Beyond The FISH.

(H012) Supplemental Validation of the Genomic Profiling Assay for Hematologic Malignancies after Major Classification Updates

(H013) Characteristics of adult patients with presumable germline SAMD9/SAMD9L mutations

(H014) Comprehensive Observations of Co-occurrence of MPN Driver Mutations: JAK2, CALR, and MPL

(H015) Optical Genome Mapping for genome-wide structural variation analysis in hematologic malignancies: results of a prospective study and impact on diagnosis and management

(H016) Comparison of Three Digital Polymerase Chain Reaction Assays for Detection and Quantification of KIT p.D816V Variant Allele Frequency

(H017) Using a Targeted NGS Approach to Detect Copy Number Alterations and Gene Variants in Chronic Lymphocytic Leukemia

(H018) Clinical Validation of a Rapid Myeloid Mutation Panel

(H019) Overcoming Deficient ASXL1 Mutation Detection by Ion Torrent Oncomine Myeloid NGS Assays: Journey of a Molecular Pathology Lab

(H020) Whole Genome Sequencing Informed Patient Personalized Measurable Residual Disease Assays for Acute Myeloid Leukemia

(H021) B-cell Acute Lymphoblastic Leukemia (B-ALL) Subtype Classification by RNA Sequencing (RNA-Seq) Gene Expression Profiling is Suitable for Clinical Diagnostic Use

(H022) Chromoanagenesis: A Common Mechanism that Leads to Highly Complex Karyotype and Extensive Clonal Heterogeneity in Hematological Malignancies

(H023) Applying optical genome mapping (OGM) to detect and monitor genomic biomarkers in hematologic malignancies

(H024) Refining the Detection of ETV6 Loss in ETV6::RUNX1-like B-ALL using Multimodal Approaches

(H025) Evaluation of alpha-thalassemia genotype-phenotype in cohort Egyptian patients with hypochromic microcytic anemia

(H026) Our experience with new integrated Genexus sequencer for simultaneous detection of Somatic DNA and RNA Aberrations for myeloid neoplasms

(H027) Discovery of a germline EZH2 variant reveals Weaver syndrome during sequencing of a B-cell Acute Lymphoblastic Leukemia (B-ALL)

(H028) Novel Germline Variants in Primary Cutaneous Lymphoma Identified Using Genome-Wide Analyses of 170000 Individuals

(H029) Determining the Immune Landscape of Patients with B- and T-Cell Malignancies Utilizing Whole Transcriptome RNA-Sequencing and TRUST4

(H030) Clinical Utility of TRB Reflex Testing in the Evaluation of Cutaneous T-cell Lymphoma and Sezary Syndrome

(H031) Optimization of FLT3 Detection of Internal Tandem Duplication (ITD) at Moffitt Cancer Center

(H032) “Rule Out Myeloid Malignancy”: Evaluation of Molecular Testing Utility for Suspected Myeloid Malignancies. A Single Institution's Experience.

(H033) Development of an External Control Panel to Confirm Linear Dynamic Range of Xpert NPM1 Mutation Assay

(H034) Rare case of Acute Promyelocytic Like Leukemia due to amplification of MYC as double minutes

(H035) Clinical Utility of Whole Exome Sequencing for Myeloid Neoplasms: A Comparative Study with Targeted Sequencing

(H036) Validation of RNA Extraction from Whole Peripheral Blood Using the Maxwell CSC RNA Blood Kit (Promega) on the Maxwell CSC 48 Instrument (Promega).

(H037) Examination of CBFB::MYH11 fusion in AML: RNA vs. Cytogenetics, Flow Cytometry, and Morphology

(H038) Optical Genome Mapping Reveals Known and Novel Chromosome Structure Across a Range of Hematological Malignancies in a Clinical Setting

(H039) Examination of RUNX1::RUNXT1 in AML: RNA vs. Cytogenetics, Flow Cytometry, and Morphology

(H040) Lymphoplasmacytic Lymphoma With MYD88 And SAMHD1 Co-Mutations

(H041) A Case of Acute Myeloid Leukemia with EWSR1::FLI1 Fusion

(H042) Case Series of BRAF V600E-mutant Acute Myeloid Leukemia (AML): A Possible Lethal Molecular Sub-group

(H043) Redesigning C-Terminal Primers for Accurate Sequencing of ABL1 Domain in BCR::ABL1 Positive Patients

(H044) Evaluation of the Genexus Purification System and Maxwell RSC Instrument on Parallel DNA and RNA Extractions

(H045) Acute Myeloid Leukemia with NUP98 Rearrangement and Partner Genes Detected by using RNA Fusion Panel

(H046) The Clinical Validation of a Targeted Next-Generation Sequencing Panel for Lymphoid Malignancies

(H047) STREAMLINED WORKFLOW FOR NGS BASED ANAYSIS OF IGH AND TRG REARRANGEMENTS IN LYMPHOPROLIFERATIVE DISORDERS

(H048) Increased Limit of Detection of Large FLT3 Internal Tandem Duplications and Streamlined Workflow for Quantification of Allele Fraction

(H049) Suitability of a routine next generation sequencing assay (NGS) for residual disease detection in acute myeloid leukemia (AML) patients

(H050) Retrospective Analysis of Diagnostic Yield of Whole Exome Sequencing/Transcriptome Sequencing and Conventional Cytogenetics Methods in Monoclonal Gammopathies in the Mount Sinai Health System (MSHS)

(H051) Utility, Impact And Challenges of Integrating Optical Genome Mapping (OGM) Technology In Routine Investigations Of Hematological Malignancies: Real-World Experience

(H052) Assessment of Acquired Copy-Neutral Loss of Heterozygosity of Chromosome 6p in Pediatric Aplastic Anemia Patients Using Clinical Single Nucleotide Polymorphism Microarray Analysis

(H053) Analytical and Clinical Validation of Duoseq, a Novel Assay for Rapid, On-site Clinical DNA and RNA Sequencing of Hematologic Malignancies

(H054) A Rare Case of Essential Thrombocythemia Progressed to Acute Myeloid Leukemia with Concomitant JAK2, CALR, and MPL Mutations

(H055) Circulating tumor DNA-based characterization of copy number and structural variants in diffuse large B-cell lymphoma by targeted hybrid-capture based deep sequencing

(H056) A New Next-generation sequencing based assay for BCR-ABL1 kinase domain mutation detection in patients with chronic myeloid leukemia

(H057) Rare Cases Of Histiocytic Sarcoma With Therapeutically Targetable BRAF V600E Transformed From Low-Grade B-Cell Lymphomas

(H058) Pathogenic UBA1 mutations predispose male patients to myeloid neoplasms

(H059) A comparison study of mutation detection and allele frequency calling between unbiased genome-wide approaches and targeted NGS in pediatric myeloid neoplasms

(H061) Longitudinal evaluation of clone size and architecture by serial sequencing of myeloid neoplasms

(H062) Comprehensive Molecular Profiling of B-Lymphoblastic Leukemia/Lymphoma by Whole Genome Sequencing

(H063) Prototype RT-qPCR PML::RARA Reagents and a Commercial PML-RARA Kit Yield Highly Correlated Results

(H064) Pattern of expression of ALDH1a1 in non-Hodgkin lymphomas: a comparative molecular study with promising prognostic features

(H065) Comprehensive Mutational Profiling of Pediatric Acute Myeloid Leukemias Diagnosed at a Single Center (2022 WHO-HAEM5 Classification)